Italia Markets close in 5 mins

    [video]VIDEO: Futures Expert Carley Garner Sees S&P 500 at These 3 Numbers

    Over the next few weeks to some point in 2024, Garner sees swings in the S&P that start with 4730, slip as low as 4300 and go then up to ... well, you'll have to watch the Daily Rundown for that.


    A Calculated Look at Texas Instruments

    The company is a leader in the semiconductor space

  • Reuters

    UPDATE 1-US approves two gene therapies for sickle cell disease

    The U.S. Food and Drug Administration on Friday approved two gene therapies for sickle cell disease from Vertex Pharmaceuticals and CRISPR Therapeutics , as well as from bluebird bio. Sickle cell disease is a painful, inherited blood disorder that can be debilitating and lead to premature death. In sickle cell disease, the body makes flawed, sickle-shaped hemoglobin, impairing the ability of red blood cells to properly carry oxygen to the body's tissues.